Fulgent Genetics, Inc. FLGT Business Segments
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Revenue by Business | ||||||
| Laboratory Services | $71.05M-14.4% | $83.03M-1.1% | $83.93M+2.6% | $81.8M+11.4% | $73.46M-3.6% | |
| Therapeutic Development | $87K-71.8% | $309K+124% | $138K— | $0— | $0— | |
| Revenue by Geography | ||||||
| Non Us | $6.03M-28.4% | $8.43M+30.4% | $6.46M+15.5% | $5.6M-0.7% | $5.64M-8.1% | |
| Other Countries | $3.47M-5.2% | $3.67M+10.0% | $3.33M+4.5% | $3.19M+5.4% | $3.03M+5.7% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Fulgent Genetics, Inc. break its business down?
- Fulgent Genetics, Inc. (FLGT) reports revenue by business across 2 parts — Laboratory Services and Therapeutic Development. Each is extracted from the segment footnotes and tracked over time.
- Where does Fulgent Genetics, Inc.'s segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Fulgent Genetics, Inc.'s SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
